Together with other medications, Carfilzomib injection is used for the treatment of patients with multiple myeloma who have previously taken treatment with other agents.
The usually varies depending on non-branded, also named generic, to branded drugs.
Carfilzomib specifically falls under the class of agents named proteasome inhibitors. It works in order to inhibit or slow down the growth of cancerous cells in a patient's body.
Carfilzomib comes in the form of powder to be mixed with liquid to be injected into a vein by a healthcare professional usually over a period of 10 or 30 minutes.